Search Results 561-570 of 16059 for pharmacogenetics
The Knowledge Synthesis Program in the Mayo Clinic Kern Center for the Science of Health Care Delivery identifies and examines knowledge to apply the best ...
Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Peripheral Neuropathy (CIPN) and Paclitaxel-Induced ...
S. Skeletal Development and Regeneration Research: Jennifer J. Westendorf · Somatic Mutations in Development and Aging: Alexej Abyzov · Statistical Genetics ...
To address this, Dr. Acosta and a team of Mayo Clinic researchers set out to study anti-obesity medications based on obesity phenotypes to enhance weight loss.
Add being a new father to the mix and you get a glimpse into the life of Yeng F. Her, a student in biochemistry and molecular biology in his third year at Mayo ...
About this study. This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult subjects exposed to ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Medical Professionals news and the latest information about Cancer.
The purpose of this study is to evaluate whether encorafenib plus cetuximab (EC), alone or in combination with chemotherapy, can improve clinical outcomes ...
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.